Stockreport

Mesoblast Submits Clinical Efficacy and Safety Data to FDA in Rolling Biologics License Application for Remestemcel-l [Yahoo! Finance News]

Mesoblast Limited - American Depositary Shares  (MESO) 
US:NASDAQ Investor Relations: investorsmedia.mesoblast.com
PDF Mesoblast Limited : MESO The clinical submission included analyses of 309 children with SR-aGVHD who have received remestemcel-L across three separate studies. In additi [Read more]